Genotypic Approaches to Therapy in Children (GATC): using information technology to improve drug safety.

Autor: Wong E, Carleton BC, Wright DFB, Smith MA, Verbeek L, Hildebrand CA, Stannard P, Vaillancourt R, Elliot-Miller P, Ross CJD, Hayden MR, McDaniel JG

Publikováno v: Studies in Health Technology & Informatics; 2009, Vol. 143, p209-214, 6p

Leverage points for establishing clinical decision-maker as a vital component of pharmacists' professional identity.

Autor: Anakin MG; Sydney Pharmacy School, University of Sydney, New South Wales, Australia. Electronic address: megan.anakin@sydney.edu.au., Desselle S; Touro University California College of Pharmacy, Vallejo, CA, USA., Wright DFB; Sydney Pharmacy School, University of Sydney, New South Wales, Australia; St Vincent's Clinical School, School of Medical Sciences, University of New South Wales, Sydney, Australia; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital Sydney, Darlinghurst, Australia.

Publikováno v: Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2024 Sep; Vol. 20 (9), pp. 954-957. Date of Electronic Publication: 2024 Jun 10.

The impact of peritoneal dialysis on oxypurinol and urate elimination in people with gout.

Autor: Wilson LC; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Ward J; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Wright DFB; School of Pharmacy, University of Otago, Dunedin, New Zealand.; Sydney Pharmacy School, University of Sydney, Sydney, New South Wales, Australia., Green SC; Department of Medicine, University of Otago, Christchurch, New Zealand., Stocker SL; Sydney Pharmacy School, University of Sydney, Sydney, New South Wales, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital Sydney, Sydney, New South Wales, Australia.; Sydney Musculoskeletal Health, Univ. of Sydney, Sydney, New South Wales, Australia., Putt TL; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Schollum JBW; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand., Walker RJ; Department of Medicine, Dunedin School of Medicine, Dunedin, New Zealand.

Publikováno v: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2024 Aug; Vol. 29 (8), pp. 547-550. Date of Electronic Publication: 2024 Apr 16.

The experiences and perspectives of people with gout on urate self-monitoring.

Autor: Michael TJF; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Chan JS; St Vincent's Clinical School Campus, Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia., Hughes S; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Wright DFB; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; St Vincent's Clinical School Campus, Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, New South Wales, Australia., Coleshill MJ; Black Dog Institute, Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia., Hughes DA; Centre for Health Economics and Medicines Evaluation, North Wales Medical School, Bangor University, Wales, UK., Day RO; St Vincent's Clinical School Campus, Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, New South Wales, Australia., Aslani P; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Stocker SL; School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, New South Wales, Australia.; Sydney Infectious Diseases Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Musculoskeletal Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Publikováno v: Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2024 Jun; Vol. 27 (3), pp. e14071.

Estimation of adherence to urate-lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient-reported dosing.

Autor: Schulz M; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW Sydney, Sydney, NSW, Australia., Coleshill MJ; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW Sydney, Sydney, NSW, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Sydney, NSW, Australia.; Black Dog Institute, Sydney, NSW, Australia., Day RO; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW Sydney, Sydney, NSW, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Sydney, NSW, Australia., Wright DFB; School of Pharmacy, University of Otago, Dunedin, New Zealand., Brett J; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW Sydney, Sydney, NSW, Australia.; Department of Clinical Pharmacology & Toxicology, St Vincent's Hospital, Sydney, NSW, Australia., Briggs NE; Stats Central, Mark Wainwright Analytical Centre, UNSW Sydney, Sydney, Australia., Aung E; St Vincent's Clinical Campus, School of Clinical Medicine, UNSW Sydney, Sydney, NSW, Australia.; Northern Sydney Local Health District, NSW Health, Sydney, NSW, Australia.; Kolling Institute, Pain Management Research Institute, The University of Sydney, Sydney, NSW, Australia.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 May; Vol. 90 (5), pp. 1322-1332. Date of Electronic Publication: 2024 Feb 21.